Isafjordur, Iceland and Washington DC, February 26, 2015 – Kerecis, the medical fish skin company, has established an office in Washington DC and hired Chris Harte as the chief operating officer for North America.
The Kerecis Omega3 wound-treatment product is fish skin that has had its cells removed, leaving behind intact dermis that looks like skin and contains Omega3 and other skin components. When inserted into or on damaged human tissue, the Kerecis Omega3 products recruit the body’s own cells, are incorporated into the wound, and ultimately are converted into functional, living tissue.
Chris will be working closely with various entities of the U.S. Department of Defense (DoD) that Kerecis is collaborating with, and will manage the Kerecis U.S. distribution network once established. Chris will be based in the new Kerecis office in Washington DC, the first office that Kerecis has established outside of Iceland.
Chris has more than 25 years of technical and operations experience. Before joining Kerecis, he was the senior vice president of business development Americas at the enterprise resource planning company UXC Eclipse. Chris had been with the predecessor company, Tectura, since 2002. Previously, he had been operations director for Scio / GoPro in Copenhagen, Denmark. Other experience includes technical and management positions with IBM, UAB Sekasoft (Lithuania) and The Computer Group. He has resided and worked twice in Europe and once for two years in India.
He received his bachelor’s degree in history from Clemson University (Clemson, South Carolina) and his masters’ in business administration (MBA) from the University of South Carolina.
“I have worked with Chris in the past and know that his combination of operations, marketing and technical skills will be a great asset to us as we expand in the United States,” said G. Fertram Sigurjonsson, President and CEO, Kerecis Limited.